The 152 references in paper , статья Редакционная (2014) “Измерение оксида азота в выдыхаемом воздухе для диагностики бронхолегочных заболеваний // Measurement of nitric oxide in the exhaled breath in diagnosis of pulmonary disease” / spz:neicon:pulmonology:y:2012:i:1:p:11-26

1
Ignarro L.J., Buga G.M., Wood K.S. et al. Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl Acad. Sci. USA 1987; 84: 9265–9269.
(check this in PDF content)
2
Palmer R.M., Ashton D.S., Moncada S.Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664–666.
(check this in PDF content)
3
Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915–918.
(check this in PDF content)
4
Dweik R.A., Comhair S.A., Gaston B. et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc. Natl Acad. Sci. USA 2001; 98: 2622–2627.
(check this in PDF content)
5
Guo F.H., Comhair S.A., Zheng S. et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and posttranslational regulation of NO synthesis. J. Immunol. 2000; 164: 5970–5980.
(check this in PDF content)
6
Ricciardolo F.L. Multiple roles of nitric oxide in the airways. Thorax 2003; 58: 175–182.
(check this in PDF content)
7
Khatri S.B., Hammel J., Kavuru M.S. et al.Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge. J. Appl. Physiol. 2003; 95: 436–440; discuss.: 435.
(check this in PDF content)
8
Khatri S.B., Ozkan M., McCarthy K. et al. Alterations in exhaled gas profile during allergeninduced asthmatic response. Am. J. Respir. Crit. Care Med. 2001; 164: 1844–1848.
(check this in PDF content)
9
Reid D.W., Johns D.P., Feltis B. et al. Exhaled nitric oxide continues to reflect airway hyperresponsiveness and disease activity in inhaled corticosteroid-treated adult asthmatic patients. Respirology 2003; 8: 479–486.
(check this in PDF content)
10
Sanctis G.T., MacLean J.A., Hamada K. et al. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J. Exp. Med. 1999; 189: 1621–1630.
(check this in PDF content)
11
Lane C., Knight D., Burgess S. et al.Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 2004; 59: 757–760.
(check this in PDF content)
12
Guo F.H., De Raeve H.R., Rice T.W. et al.Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl Acad. Sci. USA 1995; 92: 7809–7813.
(check this in PDF content)
13
Guo F.H., Erzurum S.C. Characterization of inducible nitric oxide synthase expression in human airway epithelium. Environ Hlth Perspect. 1998; 106: 1119–1124.
(check this in PDF content)
14
Dweik R.A., Erzurum S.C. Regulation of nitric oxide (NO) synthases and gas phase NO by oxygen. In: Marczin N., Kharitonov S.A., Yacoub M.H., Barnes P.J., eds. Disease 23 Клинические рекомендации markers in exhaled breath (lung biology in health and disease). New York: Marcel Dekker Inc.; 2003. 235–246.
(check this in PDF content)
15
Hansel T.T., Kharitonov S.A., Donnelly L.E. et al.A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J. 2003; 17: 1298–1300.
(check this in PDF content)
16
Guo F.H., Uetani K., Haque S.J. et al.Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 1997; 100: 829–838.
(check this in PDF content)
17
Gustafsson L.E., Leone A.M., Persson M.G. et al. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 1991; 181: 852–857.
(check this in PDF content)
18
Alving K., Weitzberg E., Lundberg J.M.Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J.
(check this in PDF content)
19
3; 6: 1368–1370. 19.Kharitonov S.A., Yates D., Robbins R.A. et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133–135.
(check this in PDF content)
20
Gaston B., Drazen J., Chee C.B.E. et al.Expired nitric oxide concentrations are elevated in patients with reactive airways disease. Endothelium 1993; 1: 87–92.
(check this in PDF content)
21
Silkoff P.E., McClean P., Spino M. et al. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001; 119: 1322–1328.
(check this in PDF content)
22
Ozkan M., Dweik R.A. Nitric oxide and airway reactivity. Clin. Pulm. Med. 2001; 8: 199–206.
(check this in PDF content)
23
Smith A.D., Cowan J.O., Filsell S. et al.Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am. J. Respir. Crit. Care Med. 2004; 169: 473–478.
(check this in PDF content)
24
Khalili B., Boggs P.B., Shi R., Bahna S.L. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann. Allergy Asthma Immunol. 2008; 101: 124–129.
(check this in PDF content)
25
Dweik R.A.The promise and reality of nitric oxide in the diagnosis and treatment of lung disease. Cleveland Clin. J. Med. 2001; 68: 486, 488, 490, 493.
(check this in PDF content)
26
American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am. J. Respir. Crit. Care Med. 1999; 160: 2104–2117.
(check this in PDF content)
27
American Thoracic Society / European Respiratory Society. ATS / ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am. J. Respir. Crit. Care Med. 2005; 171: 912–930.
(check this in PDF content)
28
Grob N.M., Dweik R.A. Exhaled nitric oxide in asthma. From diagnosis, to monitoring, to screening: are we there yet? Chest 2008; 133: 837–839.
(check this in PDF content)
29
Guyatt G., Vist G., Falck-Ytter Y. et al.An emerging consensus on grading recommendations? Evid. Based Med. 2006; 11: 2–4.
(check this in PDF content)
30
Schunemann H.J., Jaeschke R., Cook D.J. et al.An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am. J. Respir. Crit. Care Med. 2006; 174: 605–614.
(check this in PDF content)
31
Cowan D.C., Cowan J.O., Palmay R. et al.Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010; 65: 384–390.
(check this in PDF content)
32
Wenzel S.E. Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both? Am. J. Respir. Crit. Care Med. 2004; 170: 579–580.
(check this in PDF content)
33
Moore W.C., Bleecker E.R., Curran-Everett D. et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J. Allergy Clin. Immunol. 2007; 119: 405–413.
(check this in PDF content)
34
Moore W.C., Meyers D.A., Wenzel S.E. et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am. J. Respir. Crit. Care Med. 2010; 181: 315–323.
(check this in PDF content)
35
Dweik R.A., Sorkness R.L., Wenzel S. et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am. J. Respir. Crit. Care Med. 2010; 181: 1033–1041.
(check this in PDF content)
36
Mattes J., Storm van's Gravesande K., Reining U. et al.NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur. Respir. J. 1999; 13: 1391–1395.
(check this in PDF content)
37
Bousquet J., Chanez P., Lacoste J.Y. et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990; 323: 1033–1039.
(check this in PDF content)
38
Green R.H., Brightling C.E., McKenna S. et al.Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715–1721.
(check this in PDF content)
39
Berry M.A., Shaw D.E., Green R.H. et al. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin. Exp. Allergy 2005; 35: 1175–1179.
(check this in PDF content)
40
Warke T.J., Fitch P.S., Brown V. et al.Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002; 57: 383–387.
(check this in PDF content)
41
Silkoff P.E., Lent A.M., Busacker A.A. et al.Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J. Allergy Clin. Immunol. 2005; 116: 1249–1255.
(check this in PDF content)
42
Brown H.M. Treatment of chronic asthma with prednisolone; significance of eosinophils in the sputum. Lancet 1958; 2: 1245–1247.
(check this in PDF content)
43
Paoliello-Paschoalato A.B., Oliveira S.H., Cunha F.Q. Interleukin 4 induces the expression of inducible nitric oxide synthase in eosinophils. Cytokine 2005; 30: 116–124.
(check this in PDF content)
44
Barreto M., Villa M.P., Monti F. et al.Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms. Pediatr. Allergy Immunol. 2005; 16: 52–58.
(check this in PDF content)
45
Strunk R.C., Szefler S.J., Phillips B.R. et al.Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J. Allergy Clin. Immunol. 2003; 112: 883–892.
(check this in PDF content)
46
Toorn L.M., Overbeek S.E., de Jongste J.C. et al. Airway inflammation is present during clinical remission of atopic asthma. Am. J. Respir. Crit. Care Med. 2001; 164: 2107–2113.
(check this in PDF content)
47
Payne D.N., Adcock I.M., Wilson N.M. et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am. J. Respir. Crit. Care Med. 2001; 164: 1376–1381.
(check this in PDF content)
48
Lim S., Jatakanon A., Meah S. et al.Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000; 55: 184–188.
(check this in PDF content)
49
Jatakanon A., Lim S., Kharitonov S.A. et al.Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91–95.
(check this in PDF content)
50
Jones S.L., Kittelson J., Cowan J.O. et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am. J. Respir. Crit. Care Med. 2001; 164: 738–743.
(check this in PDF content)
51
Shaw D.E., Berry M.A., Thomas M. et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2007; 176: 231–237.
(check this in PDF content)
52
Porsbjerg C., Lund T.K., Pedersen L., Backer V. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J. Asthma 2009; 46: 606–612.
(check this in PDF content)
53
Fabbri L.M., Romagnoli M., Corbetta L. et al.Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2003; 167: 418–424.
(check this in PDF content)
54
Brightling C.E., Symon F.A., Birring S.S. et al.Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003; 58: 528–532.
(check this in PDF content)
55
Szefler S.J., Martin R.J.Lessons learned from variation in response to therapy in clinical trials. J. Allergy Clin. Immunol. 2010; 125: 285–292; quiz.: 293–294.
(check this in PDF content)
56
Smith A.D., Cowan J.O., Brassett K.P. et al.Exhaled nitric oxide: a predictor of steroid response. Am. J. Respir. Crit. Care Med. 2005; 172: 453–459.
(check this in PDF content)
57
Szefler S.J., Martin R.J., King T.S. et al.Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol. 2002; 109: 410–418.
(check this in PDF content)
58
Knuffman J.E., Sorkness C.A., Lemanske R.F. et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J. Allergy Clin. Immunol. 2009; 123: 411–416.
(check this in PDF content)
59
Pijnenburg M.W., Hofhuis W., Hop W.C., De Jongste J.C. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60: 215–218.
(check this in PDF content)
60
Zacharasiewicz A., Wilson N., Lex C. et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am. J. Respir. Crit. Care Med. 2005; 171: 1077–1082.
(check this in PDF content)
61
Deykin A., Massaro A.F., Drazen J.M., Israel E.Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am. J. Respir. Crit. Care Med. 2002; 165: 1597–1601.
(check this in PDF content)
62
Berkman N., Avital A., Breuer R. et al.Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 2005; 60: 383–388.
(check this in PDF content)
63
Ihre E., Gustafsson L.E., Kumlin M. et al.Early rise in exhaled no and mast cell activation in repeated low dose allergen challenge. Eur. Respir. J. 2006; 27: 1152–1159.
(check this in PDF content)
64
Meurs H., Maarsingh H., Zaagsma J.Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 2003; 24: 450–455.
(check this in PDF content)
65
Dupont L.J., Rochette F., Demedts M.G., Verleden G.M. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am. J. Respir. Crit. Care Med. 1998; 157: 894–898.
(check this in PDF content)
66
Gronke L., Kanniess F., Holz O. et al. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin. Exp. Allergy 2002; 32: 57–63.
(check this in PDF content)
67
Lapperre T.S., Snoeck-Stroband J.B., Gosman M.M. et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 170: 499–504.
(check this in PDF content)
68
Rosi E., Ronchi M.C., Grazzini M. et al. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 1999; 103: 232–237.
(check this in PDF content)
69
Olin A.C., Bake B., Toren K.Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong neversmokers. Chest 2007; 131: 1852–1856.
(check this in PDF content)
70
Arora R., Thornblade C.E., Dauby P.A. et al.Exhaled nitric oxide levels in military recruits with new onset asthma. Allergy Asthma Proc. 2006; 27: 493–498.
(check this in PDF content)
71
Deykin A., Massaro A.F., Coulston E. et al. Exhaled nitric oxide following repeated spirometry or repeated plethysmography in healthy individuals. Am. J. Respir. Crit. Care Med. 2000; 161: 1237–1240.
(check this in PDF content)
72
Dupont L.J., Demedts M.G., Verleden G.M.Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003; 123: 751–756.
(check this in PDF content)
73
Olin A.C., Rosengren A., Thelle D.S. et al.Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006; 130: 1319–1325.
(check this in PDF content)
74
Borrill Z., Clough D., Truman N. et al. A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir. Med. 2006; 100: 1392–1396.
(check this in PDF content)
75
Kharitonov S.A., Gonio F., Kelly C. et al.Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur. Respir. J. 2003; 21: 433–438.
(check this in PDF content)
76
Buchvald F., Baraldi E., Carraro S. et al.Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J. Allergy Clin. Immunol. 2005; 115: 1130–1136.
(check this in PDF content)
77
Olivieri M., Talamini G., Corradi M. et al. Reference values for exhaled nitric oxide (reveno) study. Respir. Res. 2006; 7: 94.
(check this in PDF content)
78
Travers J., Marsh S., Aldington S. et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am. J. Respir. Crit. Care Med. 2007; 176: 238–242.
(check this in PDF content)
79
Dressel H., de la Motte D., Reichert J. et al.Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir. Med. 2008; 102: 962–969.
(check this in PDF content)
80
Baraldi E., Azzolin N.M., Cracco A., Zacchello F. Reference values of exhaled nitric oxide for healthy children 6–15 years old. Pediatr. Pulmonol. 1999; 27: 54–58.
(check this in PDF content)
81
Kovesi T., Kulka R., Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest 2008; 133: 169–175.
(check this in PDF content)
82
Wong G.W., Liu E.K., Leung T.F. et al.High levels and gender difference of exhaled nitric oxide in Chinese schoolchildren. Clin. Exp. Allergy 2005; 35: 889–893.
(check this in PDF content)
83
Malmberg L.P., Petays T., Haahtela T. et al.Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr. Pulmonol. 2006; 41: 635–642.
(check this in PDF content)
84
Taylor D.R., Mandhane P., Greene J.M. et al.Factors affecting exhaled nitric oxide measurements: the effect of sex. Respir. Res. 2007; 8: 82.
(check this in PDF content)
85
Meijer R.J., Postma D.S., Kauffman H.F. et al. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin. Exp. Allergy 2002; 32: 1096–1103. 25 Клинические рекомендации
(check this in PDF content)
86
Szefler S.J., Phillips B.R., Martinez F.D. et al.Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J. Allergy Clin. Immunol. 2005; 115: 233–242.
(check this in PDF content)
87
Pijnenburg M.W., Bakker E.M., Lever S. et al.High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Clin. Exp. Allergy 2005; 35: 920–925.
(check this in PDF content)
88
Piacentini G.L., Bodini A., Costella S. et al. Allergen avoidance is associated with a fall in exhaled nitric oxide in asthmatic children. J. Allergy Clin. Immunol. 1999; 104: 1323–1324.
(check this in PDF content)
89
Vahlkvist S., Sinding M., Skamstrup K., Bisgaard H.Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J. Allergy Clin. Immunol. 2006; 117: 1272–1276.
(check this in PDF content)
90
Pedroletti C., Millinger E., Dahlen B. et al.Clinical effects of purified air administered to the breathing zone in allergic asthma: a double-blind randomized cross-over trial. Respir. Med. 2009; 103: 1313–1319.
(check this in PDF content)
91
Bodini A., Peroni D., Loiacono A. et al. Exhaled nitric oxide daily evaluation is effective in monitoring exposure to relevant allergens in asthmatic children. Chest 2007; 132: 1520–1525.
(check this in PDF content)
92
Smith A.D., Cowan J.O., Taylor D.R. Exhaled nitric oxide levels in asthma: personal best versus reference values. J. Allergy Clin. Immunol. 2009; 124: 714–718.
(check this in PDF content)
93
Buchvald F., Eiberg H., Bisgaard H.Heterogeneity of FeNO response to inhaled steroid in asthmatic children. Clin. Exp. Allergy 2003; 33: 1735–1740.
(check this in PDF content)
94
Gelb A.F., Flynn Taylor C., Shinar C.M. et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006; 129: 1492–1499.
(check this in PDF content)
95
Szefler S.J., Mitchell H., Sorkness C.A. et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372: 1065–1072.
(check this in PDF content)
96
Ekroos H., Karjalainen J., Sarna S. et al.Shortterm variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects. Respir. Med. 2002; 96: 895–900.
(check this in PDF content)
97
Pijnenburg M.W., Floor S.E., Hop W.C., De Jongste J.C. Daily ambulatory exhaled nitric oxide measurements in asthma. Pediatr. Allergy Immunol. 2006; 17: 189–193.
(check this in PDF content)
98
Massaro A.F., Gaston B., Kita D. et al. Expired nitric oxide levels during treatment of acute asthma. Am. J. Respir. Crit. Care Med. 1995; 152: 800–803.
(check this in PDF content)
99
Beck-Ripp J., Griese M., Arenz S. et al. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur. Respir. J. 2002; 19: 1015–1019.
(check this in PDF content)
100
Michils A., Baldassarre S., Van Muylem A.Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur. Respir. J. 2008; 31: 539–546.
(check this in PDF content)
101
Jongste J.C., Carraro S., Hop W.C., Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am. J. Respir. Crit. Care Med. 2009; 179: 93–97.
(check this in PDF content)
102
Petsky H.L., Cates C.J., Lasserson T.J. et al.A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2010.
(check this in PDF content)
103
Smith A.D., Cowan J.O., Brassett K.P. et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 2005; 352: 2163–2173.
(check this in PDF content)
104
Gibson P.G. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma Treatment ALgorithm studies. Clin. Exp. Allergy 2009; 39: 478–490.
(check this in PDF content)
105
Perez-de-Llano L.A., Carballada F., Castro Anon O. et al. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur. Respir. J. 2010; 35: 1221–1227.
(check this in PDF content)
106
Barnes P.J., Dweik R.A., Gelb A.F. et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010; 138: 682–692.
(check this in PDF content)
107
Pizzichini E., Pizzichini M.M., Gibson P. et al.Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am. J. Respir. Crit. Care Med. 1998; 158: 1511–1517.
(check this in PDF content)
108
Brightling C.E., Monteiro W., Ward R. et al.Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2000; 356: 1480–1485.
(check this in PDF content)
109
Zietkowski Z., Kucharewicz I., Bodzenta-Lukaszyk A. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. Respir. Med. 2005; 99: 816–824.
(check this in PDF content)
110
Laurentiis G., Maniscalco M., Cianciulli F. et al.Exhaled nitric oxide monitoring in COPD using a portable analyzer. Pulm. Pharmacol. Ther. 2008; 21: 689–693.
(check this in PDF content)
111
Dummer J.F., Epton M.J., Cowan J.O. et al.Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 2009; 180: 846–852.
(check this in PDF content)
112
Lehtimaki L., Kankaanranta H., Saarelainen S. et al. Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. Eur. Respir. J. 2010; 35: 72–78.
(check this in PDF content)
113
Giaid A., Saleh D.Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 1995; 333: 214–221.
(check this in PDF content)
114
Ghamra Z.W., Dweik R.A. Primary pulmonary hypertension: an overview of epidemiology and pathogenesis. Cleveland Clin. J. Med. 2003; 70: S2–S8.
(check this in PDF content)
115
Mayer B., Pfeiffer S., Schrammel A. et al. A new pathway of nitric oxide / cyclic GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 1998; 273: 3264–3270.
(check this in PDF content)
116
Kim S.F., Huri D.A., Snyder S.H. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005; 310: 1966–1970.
(check this in PDF content)
117
Schmidt H.H., Hofmann H., Schindler U. et al. NO from NO synthase. Proc. Natl Acad. Sci. USA 1996; 93: 14492–14497.
(check this in PDF content)
118
Lim K.H., Ancrile B.B., Kashatus D.F., Counter C.M. Tumour maintenance is mediated by eNOS. Nature 2008; 452: 646–649.
(check this in PDF content)
119
Gaston B., Singel D., Doctor A., Stamler J.S.S-nitrosothiol signaling in respiratory biology. Am. J. Respir. Crit. Care Med. 2006; 173: 1186–1193.
(check this in PDF content)
120
Moya M.P., Gow A.J., Califf R.M. et al.Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet 2002; 360: 141–143.
(check this in PDF content)
121
Archer S., Rich S.Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". Circulation 2000; 102: 2781–2791.
(check this in PDF content)
122
Dweik R. Pulmonary hypertension and the search for the selective pulmonary vasodilator. Lancet 2002; 360: 886.
(check this in PDF content)
123
Kaneko F.T., Arroliga A.C., Dweik R.A. et al. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1998; 158: 917–923.
(check this in PDF content)
124
Dweik R.A. The lung in the balance: arginine, methylated arginines, and nitric oxide. Am. J. Physiol. Lung Cell Mol. Physiol. 2007; 292: L15–L17.
(check this in PDF content)
125
Ozkan M., Dweik R.A., Laskowski D. et al. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung 2001; 179: 233–243.
(check this in PDF content)
126
Girgis R.E., Champion H.C., Diette G.B. et al. Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. Am. J. Respir. Crit. Care Med. 2005; 172: 352–357.
(check this in PDF content)
127
Machado R.F., Londhe Nerkar M.V., Dweik R.A. et al. Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. Free Radic. Biol. Med. 2004; 37: 1010–1017.
(check this in PDF content)
128
Lundberg J.O.N., Farkas-Szallasi T., Weitzberg E. et al. High nitric oxide production in human paranasal sinuses. Nature Med. 1995; 1: 370–373.
(check this in PDF content)
129
Lundberg J.O., Weitzberg E., Nordvall S.L. et al.Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur. Respir. J. 1994; 7: 1501–1504.
(check this in PDF content)
130
Palm J.P., Graf P., Lundberg J.O., Alving K.Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements. Eur. Respir. J. 2000; 16: 236–241.
(check this in PDF content)
131
Lundberg J.O.N., Nordvall S.L., Weitzberg E. et al. Exhaled NO in pediatric asthma and cystic fibrosis. Arch. Dis. Child. 1996; 75: 323–326.
(check this in PDF content)
132
Balfour-Lynn I.M., Laverty A., Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch. Dis. Child. 1996; 75: 319–322.
(check this in PDF content)
133
Arnal J.F., Didier A., Rami J. et al. Nasal nitric oxide is increased in allergic rhinitis. Clin. Exp. Allergy 1997; 27: 358–362.
(check this in PDF content)
134
Kharitonov S.A., Rajakulasingam K., O'Connor B. et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J. Allergy Clin. Immunol. 1997; 99: 58–64.
(check this in PDF content)
135
Horvath I., Loukides S., Wodehouse T. et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003; 58: 68–72.
(check this in PDF content)
136
Karadag B., James A.J., Gultekin E. et al.Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur. Respir. J. 1999; 13: 1402–1405.
(check this in PDF content)
137
Wodehouse T., Kharitonov S.A., Mackay I.S. et al. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur. Respir. J. 2003; 21: 43–47.
(check this in PDF content)
138
Bodini A., Rugolotto S., Pradal U. et al.Nasal nitric oxide for early diagnosis of familial primary ciliary dyskinesia. Arch. Dis. Child. 2008; 93: 452–453.
(check this in PDF content)
139
Stehling F., Roll C., Ratjen F., Grasemann H.Nasal nitric oxide to diagnose primary ciliary dyskinesia in newborns. Arch. Dis. Child. Fetal Neonatal. Ed. 2006; 91: F233.
(check this in PDF content)
140
Zheng S., Xu W., Bose S. et al. Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am. J. Physiol. Lung Cell Mol. Physiol 2004; 287: L374–L381.
(check this in PDF content)
141
Kelley T.J., Drumm M.L. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. 1998; 102: 1200–1207.
(check this in PDF content)
142
Meng Q.H., Springall D.R., Bishop A.E. et al.Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J. Pathol. 1998; 184: 323–331.
(check this in PDF content)
143
Grasemann H., Kurtz F., Ratjen F.Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174: 208–212.
(check this in PDF content)
144
Jones K.L., Hegab A.H., Hillman B.C. et al. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr. Pulmonol. 2000; 30: 79–85.
(check this in PDF content)
145
Snyder A.H., McPherson M.E., Hunt J.F. et al. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 165: 922–926.
(check this in PDF content)
146
Yoon S.S., Coakley R., Lau G.W. et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 2006; 116: 436–446.
(check this in PDF content)
147
Gaston B., Ratjen F., Vaughan J.W. et al.Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am. J. Respir. Crit. Care Med. 2002; 165: 387–390.
(check this in PDF content)
148
Lara A., Khatri S.B., Wang Z. et al.Alterations of the arginine metabolome in asthma. Am. J. Respir. Crit. Care Med. 2008; 178: 673–681.
(check this in PDF content)
149
Ferrazzoni S., Scarpa M.C., Guarnieri G. et al. Exhaled nitric oxide and breath condensate ph in asthmatic reactions induced by isocyanates. Chest 2009; 136: 155–162.
(check this in PDF content)
150
Hewitt R.S., Smith A.D., Cowan J.O. et al. Serial exhaled nitric oxide measurements in the assessment of laboratory animal allergy. J. Asthma 2008; 45: 101–107.
(check this in PDF content)
151
Reddel H.K., Taylor D.R., Bateman E.D. et al. An official American Thoracic Society / European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med. 2009; 180: 59–99.
(check this in PDF content)
152
Hankinson J.L., Odencrantz J.R., Fedan K.B.Spirometric
(check this in PDF content)